Search Results - "Borgeson, Daniel D"

Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure by Miller, Wayne L., Borgeson, Daniel D., Grantham, J. Aaron, Luchner, Andreas, Redfield, Margaret M., Burnett Jr, John C.

“…Aims Aldosterone activation is central to the sodium–fluid retention that marks the progression of heart failure (HF). The actions of dietary sodium…”
Get full text

Myocarditis After BNT162b2 and mRNA-1273 Vaccination by Larson, Kathryn F., Ammirati, Enrico, Adler, Eric D., Cooper, Leslie T., Hong, Kimberly N., Saponara, Gianluigi, Couri, Daniel, Cereda, Alberto, Procopio, Antonio, Cavalotti, Cristina, Oliva, Fabrizio, Sanna, Tommaso, Ciconte, Vincenzo Antonio, Onyango, George, Holmes, David R., Borgeson, Daniel D.

“…Supplemental Digital Content is available in the text…”
Get full text

ECG-Gated Cardiac CT Angiography Using 64-MDCT for Detection of Patent Foramen Ovale by Williamson, Eric E, Kirsch, Jacobo, Araoz, Philip A, Edmister, Whitney B, Borgeson, Daniel D, Glockner, James F, Breen, Jerome F

“…The purpose of our study was to show the feasibility of ECG-gated, 64-MDCT cardiac angiography for the detection of patent foramen ovale (PFO). Chart review…”
Get full text

Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure by Luchner, A, Stevens, T L, Borgeson, D D, Redfield, M, Wei, C M, Porter, J G, Burnett, Jr, J C

“…Although brain natriuretic peptide (BNP) of myocardial origin is important in cardiovascular and renal function and as a marker of cardiac dysfunction, the…”
Get full text

Artificial Intelligence–Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis by Grogan, Martha, Lopez-Jimenez, Francisco, Cohen-Shelly, Michal, Dispenzieri, Angela, Attia, Zachi I., Abou Ezzedine, Omar F., Lin, Grace, Kapa, Suraj, Borgeson, Daniel D., Friedman, Paul A., Murphree, Dennis H.

“…To develop an artificial intelligence (AI)–based tool to detect cardiac amyloidosis (CA) from a standard 12-lead electrocardiogram (ECG). We collected 12-lead…”
Get full text

The Forgotten Valve: Isolated Severe Tricuspid Valve Stenosis by Al-Hijji, Mohammed, Yoon Park, Jae, El Sabbagh, Abdallah, Amin, Muhammad, Maleszewski, Joseph J, Borgeson, Daniel D

Get full text

Increased prevalence of diastolic dysfunction in rheumatoid arthritis by Liang, Kimberly P, Myasoedova, Elena, Crowson, Cynthia S, Davis, John M, Roger, Véronique L, Karon, Barry L, Borgeson, Daniel D, Therneau, Terry M, Rodeheffer, Richard J, Gabriel, Sherine E

“…To compare the prevalence of left ventricular (LV) diastolic dysfunction in subjects with and without rheumatoid arthritis (RA), among those with no history of…”
Get more information

Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis by Amadio, Jennifer M, Grogan, Martha, Muchtar, Eli, Lopez-Jimenez, Francisco, Attia, Zachi I, AbouEzzeddine, Omar, Lin, Grace, Dasari, Surendra, Kapa, Suraj, Borgeson, Daniel D, Friedman, Paul A, Gertz, Morie A, Murphree, Jr, Dennis H, Dispenzieri, Angela

“…We aim to determine if our previously validated, diagnostic artificial intelligence (AI) electrocardiogram (ECG) model is prognostic for survival among…”
Get full text

Echocardiographic Variables After Left Ventricular Assist Device Implantation Associated With Adverse Outcome by TOPILSKY, Yan, HASIN, Tal, MALTAIS, Simon, KUSHWAHA, Sudhir S, PEREIRA, Naveen L, PARK, Soon J, OH, Jae K, BORGESON, Daniel D, BOILSON, Barry A, SCHIRGER, John A, CLAVELL, Alfredo L, FRANTZ, Robert P, TSUTSUI, Rayji, MINGYA LIU

“…Operative mortality after left ventricular assist device (LVAD) implantation is heavily influenced by patient selection and the technical difficulty of…”
Get full text

Aflibercept and its role in the treatment of colorectal cancer--letter by Sinicrope, Frank A, Williamson, Eric E, Borgeson, Daniel D

Get full text

Impact of acute left ventricular apical thrombus on cardioversion for atrial fibrillation by Vaidya, Vaibhav R., Prueksaritanond, Suartcha, Bois, John P., Nadipalli, Abhinav, Borgeson, Daniel D., Melduni, Rowlens M.

“…Among patients undergoing cardioversion for atrial fibrillation, the presence of left ventricular thrombus is a relatively uncommon and challenging clinical…”
Get full text

Chronic Oral Endothelin Type A Receptor Antagonism in Experimental Heart Failure by Borgeson, Daniel D, Grantham, Aaron J, Williamson, Eric E, Luchner, Andreas, Redfield, Margaret M, Opgenorth, Terry J, Burnett, John C

“…Endothelin-1 (ET-1) is a cardiovascular peptide that binds to two distinct receptors, ETA and ETB, resulting in systemic and regional vasoconstriction,…”
Get full text

Mitral regurgitation in patients with advanced systolic heart failure by Patel, Jeetendra B, Borgeson, Daniel D, Barnes, Marion E, Rihal, Charanjit S, Daly, Richard C, Redfield, Margaret M

“…Mitral regurgitation (MR) may develop in patients with advanced systolic congestive heart failure (CHF) without organic mitral valve disease and contribute to…”
Get full text

Adrenomedullin in experimental congestive heart failure: cardiorenal activation by Jougasaki, M, Stevens, T L, Borgeson, D D, Luchner, A, Redfield, M M, Burnett, Jr, J C

“…Adrenomedullin (ADM) is a new member of a family of vasodilating and natriuretic peptides that plays an important role in cardiorenal regulation. This study…”
Get full text

Angiotensin II in the Evolution of Experimental Heart Failure by Luchner, Andreas, Stevens, Tracy L, Borgeson, Daniel D, Redfield, Margaret M, Bailey, Jane E, Sandberg, Sharon M, Heublein, Denise M, Burnett, John C. Jr

“…Although angiotensin II (Ang II) has been implicated in the pathophysiology of congestive heart failure, its temporal and regional changes during the…”
Get full text

Brief Report: Rheumatoid Arthritis Is Associated With Left Ventricular Concentric Remodeling: Results of a Population‐Based Cross‐Sectional Study by Myasoedova, Elena, Davis, John M., Crowson, Cynthia S., Roger, Véronique L., Karon, Barry L., Borgeson, Daniel D., Therneau, Terry M., Matteson, Eric L., Rodeheffer, Richard J., Gabriel, Sherine E.

“…Objective To study left ventricular (LV) geometry in patients with rheumatoid arthritis (RA) and no history of heart failure compared with that in subjects…”
Get full text

Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure by Martin, Fernando L., Stevens, Tracy L., Cataliotti, Alessandro, Schirger, John A., Borgeson, Daniel D., Redfield, Margaret M., Luchner, Andreas, Burnett, John C.

“…Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure. Neutral endopeptidase (NEP) degrades atrial…”
Get full text

Biomarker Responses during and after Treatment with Nesiritide Infusion in Patients with Decompensated Chronic Heart Failure by Miller, Wayne L, Hartman, Karen A, Burritt, Mary F, Borgeson, Daniel D, Burnett, John C., Jr, Jaffe, Allan S

“…Objective methods to assess the adequacy of medication therapy for patients with advanced heart failure are lacking. Serial measurements of biomarkers might be…”
Get full text

Chronic Indwelling Pleural Catheters Reduce Hospitalizations in Advanced Heart Failure with Refractory Pleural Effusions by Borgeson, Daniel D, Defranchi, Sebastian A, Lam, Carolyn S.P, Lin, Grace, Nichols, Francis C

Get full text

Abstract 13814: Prediction of Transthyretin Cardiac Amyloidosis in Heart Failure With Preserved Ejection Fraction: Artificial Intelligence Electrocardiogram versus Traditional Risk Scores by Davies, Daniel, Murphree, Dennis, Scott, Christopher, Lopez-jimenez, Francisco, Baez Suarez, Abraham, Attia, Zachi, Kapa, Suraj, Borgeson, Daniel D, FRIEDMAN, Paul A, Angela, Dispenzieri, Grogan, Martha, Redfield, Margaret M, Abouezzeddine, Omar F

“…IntroductionTransthyretin cardiac amyloidosis (TTR-CA) can cause heart failure with preserved EF (HFpEF). We previously reported a clinical/echo-based score…”
Get full text